Whit Mayo
Stock Analyst at Leerink Partners
(2.52)
# 2,432
Out of 5,090 analysts
152
Total ratings
52.58%
Success rate
10.55%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Market Perform | $25 → $14 | $14.42 | -2.88% | 11 | Dec 3, 2025 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $21.98 | -22.66% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $328.59 | -5.66% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $3.08 | -18.83% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $9.29 | +18.41% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $9.25 | -13.51% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $8.70 | +187.36% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $257.48 | -2.91% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $112.27 | -10.93% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $35.76 | -58.05% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $330.33 | +69.53% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $230.00 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $123.34 | -21.36% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $264.25 | +26.77% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $484.43 | -40.96% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $17.01 | +135.22% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $23.79 | +63.93% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.65 | -43.40% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.66 | +4,429.67% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $210.58 | -73.88% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $85.07 | +105.71% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $19.47 | -2.41% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.47 | +15.44% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $258.26 | -21.40% | 2 | May 1, 2018 |
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Market Perform
Price Target: $25 → $14
Current: $14.42
Upside: -2.88%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $21.98
Upside: -22.66%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $328.59
Upside: -5.66%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $3.08
Upside: -18.83%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $9.29
Upside: +18.41%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $9.25
Upside: -13.51%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $8.70
Upside: +187.36%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $257.48
Upside: -2.91%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $112.27
Upside: -10.93%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $35.76
Upside: -58.05%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $330.33
Upside: +69.53%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $230.00
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $123.34
Upside: -21.36%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $264.25
Upside: +26.77%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $484.43
Upside: -40.96%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $17.01
Upside: +135.22%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $23.79
Upside: +63.93%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.65
Upside: -43.40%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.66
Upside: +4,429.67%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $210.58
Upside: -73.88%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $85.07
Upside: +105.71%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $19.47
Upside: -2.41%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.47
Upside: +15.44%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $258.26
Upside: -21.40%